Lung Abnormalities in Liver Cirrhosis

Regardless of preexisting lung illness, patients suffering from liver cirrhosis, especially decompensated liver cirrhosis can develop distinct pulmonary complications. Liver cirrhosis patients should be assessed for hepatopulmonary syndrome (HPS), portopulmonary hypertension (PoPH), hepatic hydrotho...

Full description

Bibliographic Details
Main Authors: Muli Yaman, Syifa Mustika
Format: Article
Language:English
Published: Universitas Brawijaya 2023-11-01
Series:Clinical and Research Journal in Internal Medicine
Subjects:
Online Access:https://crjim.ub.ac.id/index.php/crjim/article/view/158
_version_ 1831878338315026432
author Muli Yaman
Syifa Mustika
author_facet Muli Yaman
Syifa Mustika
author_sort Muli Yaman
collection DOAJ
description Regardless of preexisting lung illness, patients suffering from liver cirrhosis, especially decompensated liver cirrhosis can develop distinct pulmonary complications. Liver cirrhosis patients should be assessed for hepatopulmonary syndrome (HPS), portopulmonary hypertension (PoPH), hepatic hydrothorax (HH) and spontaneous bacterial empyema (SBEM)  which are the most clinically significant pulmonary consequences, in particular when dyspnea develops in conjunction with hepatic cirrhosis. These entities differ in terms of pathophysiology, clinical characteristics, diagnosis and suitable treatment options. This emphasize the need of specific diagnostic algorithm in liver cirrhosis patients presenting with dyspnea or other pulmonary symptoms. These pulmonary complications might be rare in patients with liver cirrhosis and portal hypertension but these complications might carry significant morbidity and mortality risks and, therefore, strong clinical suspicion is required to make an early accurate diagnosis. There are several medical therapies available for each condition in the multiple studies but most of the treatments and proceures doesn’t have significant benefit or have short lived benefit. The only treatment that changes the clinical prognosis of decompensated cirrhosis effectively in long term is liver transplantation. However liver transplantation also needs careful considerations as on some cases it might increase the risk of morbidity and mortality.   Keywords:  Cirrhosis Hepatis, Hepatopulmonary Syndrome, Portopulmonary Hypertension, Hepatic Hydrothorax, Spontaneous Bacterial Empyema
first_indexed 2024-03-09T03:11:44Z
format Article
id doaj.art-3e842d5bf25e40e298db8a8be45a0137
institution Directory Open Access Journal
issn 2723-5130
2723-5122
language English
last_indexed 2025-03-21T21:29:43Z
publishDate 2023-11-01
publisher Universitas Brawijaya
record_format Article
series Clinical and Research Journal in Internal Medicine
spelling doaj.art-3e842d5bf25e40e298db8a8be45a01372024-05-28T07:51:25ZengUniversitas BrawijayaClinical and Research Journal in Internal Medicine2723-51302723-51222023-11-014247048010.21776/ub.crjim.2023.004.02.06108Lung Abnormalities in Liver CirrhosisMuli Yaman0Syifa Mustika1https://orcid.org/0000-0003-4831-2719Department of Pulmonology and Respiratory Medicine Faculty of Medicine, Universitas Brawijaya, Malang, IndonesiaDivision of Gastroenterohepatology, Department of Internal Medicine,Universitas Brawijaya – RSUD Dr. Saiful Anwar Malang, Indonesia Regardless of preexisting lung illness, patients suffering from liver cirrhosis, especially decompensated liver cirrhosis can develop distinct pulmonary complications. Liver cirrhosis patients should be assessed for hepatopulmonary syndrome (HPS), portopulmonary hypertension (PoPH), hepatic hydrothorax (HH) and spontaneous bacterial empyema (SBEM)  which are the most clinically significant pulmonary consequences, in particular when dyspnea develops in conjunction with hepatic cirrhosis. These entities differ in terms of pathophysiology, clinical characteristics, diagnosis and suitable treatment options. This emphasize the need of specific diagnostic algorithm in liver cirrhosis patients presenting with dyspnea or other pulmonary symptoms. These pulmonary complications might be rare in patients with liver cirrhosis and portal hypertension but these complications might carry significant morbidity and mortality risks and, therefore, strong clinical suspicion is required to make an early accurate diagnosis. There are several medical therapies available for each condition in the multiple studies but most of the treatments and proceures doesn’t have significant benefit or have short lived benefit. The only treatment that changes the clinical prognosis of decompensated cirrhosis effectively in long term is liver transplantation. However liver transplantation also needs careful considerations as on some cases it might increase the risk of morbidity and mortality.   Keywords:  Cirrhosis Hepatis, Hepatopulmonary Syndrome, Portopulmonary Hypertension, Hepatic Hydrothorax, Spontaneous Bacterial Empyemahttps://crjim.ub.ac.id/index.php/crjim/article/view/158cirrhosis hepatis, hepatopulmonary syndrome, portopulmonary hypertension, hepatic hydrothorax, spontaneous bacterial empyema
spellingShingle Muli Yaman
Syifa Mustika
Lung Abnormalities in Liver Cirrhosis
Clinical and Research Journal in Internal Medicine
cirrhosis hepatis, hepatopulmonary syndrome, portopulmonary hypertension, hepatic hydrothorax, spontaneous bacterial empyema
title Lung Abnormalities in Liver Cirrhosis
title_full Lung Abnormalities in Liver Cirrhosis
title_fullStr Lung Abnormalities in Liver Cirrhosis
title_full_unstemmed Lung Abnormalities in Liver Cirrhosis
title_short Lung Abnormalities in Liver Cirrhosis
title_sort lung abnormalities in liver cirrhosis
topic cirrhosis hepatis, hepatopulmonary syndrome, portopulmonary hypertension, hepatic hydrothorax, spontaneous bacterial empyema
url https://crjim.ub.ac.id/index.php/crjim/article/view/158
work_keys_str_mv AT muliyaman lungabnormalitiesinlivercirrhosis
AT syifamustika lungabnormalitiesinlivercirrhosis